Jan 25 (Reuters) – Moderna Inc said on Monday its COVID-19 vaccine produced virus-neutralizing antibodies against new variants of COVID-19 found in the UK and South Africa.
A two-dose regimen of the Moderna COVID-19 vaccine is expected to be protective against emerging strains detected to date, the company said. (Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)
(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.